Clinical Trials Browser

Lutetium × 30 days × Clear all

NCT05413850 2026-04-13

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Phase 1/2 Recruiting

Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05849298 2026-04-13

PSMACare

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06517719 2026-04-13

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT06894511 2026-04-08

PSMAndARPI

Phase 2 Active not recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)